CLINICAL_TRIALS
research
· 2014-08-20
Clinical Trial Update: Cryptococcal Optimal ART Timing Trial [Phase 4]
Summary
A Phase 4 trial evaluating the timing of antiretroviral therapy in cryptococcal meningitis with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Minnesota | Conditions: Cryptococcal Meningitis, HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2014-08-20